192 related articles for article (PubMed ID: 34502261)
1. Design and Characterization of a Cell-Penetrating Peptide Derived from the SOX2 Transcription Factor.
Gandhi NS; Wang E; Sorolla A; Kan YJ; Malik A; Batra J; Young KA; Tie WJ; Blancafort P; Mancera RL
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502261
[TBL] [Abstract][Full Text] [Related]
2. Cooperative DNA Recognition Modulated by an Interplay between Protein-Protein Interactions and DNA-Mediated Allostery.
Merino F; Bouvier B; Cojocaru V
PLoS Comput Biol; 2015 Jun; 11(6):e1004287. PubMed ID: 26067358
[TBL] [Abstract][Full Text] [Related]
3. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
4. Structural Mechanism behind Distinct Efficiency of Oct4/Sox2 Proteins in Differentially Spaced DNA Complexes.
Yesudhas D; Anwar MA; Panneerselvam S; Durai P; Shah M; Choi S
PLoS One; 2016; 11(1):e0147240. PubMed ID: 26790000
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for the SOX-dependent genomic redistribution of OCT4 in stem cell differentiation.
Merino F; Ng CKL; Veerapandian V; Schöler HR; Jauch R; Cojocaru V
Structure; 2014 Sep; 22(9):1274-1286. PubMed ID: 25126959
[TBL] [Abstract][Full Text] [Related]
6. Synergistic activation of the fibroblast growth factor 4 enhancer by Sox2 and Oct-3 depends on protein-protein interactions facilitated by a specific spatial arrangement of factor binding sites.
Ambrosetti DC; Basilico C; Dailey L
Mol Cell Biol; 1997 Nov; 17(11):6321-9. PubMed ID: 9343393
[TBL] [Abstract][Full Text] [Related]
7. Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.
Beltran AS; Graves LM; Blancafort P
Oncogene; 2014 Sep; 33(39):4767-77. PubMed ID: 24141779
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.
Ambrosetti DC; Schöler HR; Dailey L; Basilico C
J Biol Chem; 2000 Jul; 275(30):23387-97. PubMed ID: 10801796
[TBL] [Abstract][Full Text] [Related]
9. Impact of protein/protein interactions on global intermolecular translocation rates of the transcription factors Sox2 and Oct1 between DNA cognate sites analyzed by z-exchange NMR spectroscopy.
Takayama Y; Clore GM
J Biol Chem; 2012 Aug; 287(32):26962-70. PubMed ID: 22718759
[TBL] [Abstract][Full Text] [Related]
10. Structural Plasticity of Pioneer Factor Sox2 and DNA Bendability Modulate Nucleosome Engagement and Sox2-Oct4 Synergism.
Malaga Gadea FC; Nikolova EN
J Mol Biol; 2023 Jan; 435(2):167916. PubMed ID: 36495920
[TBL] [Abstract][Full Text] [Related]
11. NONO Is a Negative Regulator of
Liang S; Takahashi H; Hirose T; Kuramitsu Y; Hatakeyama S; Yoshiyama H; Wang R; Hamada JI; Iizasa H
Cancer Genomics Proteomics; 2020; 17(4):359-367. PubMed ID: 32576581
[TBL] [Abstract][Full Text] [Related]
12. OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer.
Zhang JM; Wei K; Jiang M
Breast Cancer; 2018 Jul; 25(4):447-455. PubMed ID: 29536377
[TBL] [Abstract][Full Text] [Related]
13. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
Bigdelou Z; Johari B; Kadivar M; Rismani E; Asadi Z; Rahmati M; Saltanatpour Z
J Cell Physiol; 2019 Dec; 234(12):22765-22774. PubMed ID: 31115051
[TBL] [Abstract][Full Text] [Related]
14. Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq.
Chang YK; Srivastava Y; Hu C; Joyce A; Yang X; Zuo Z; Havranek JJ; Stormo GD; Jauch R
Nucleic Acids Res; 2017 Jan; 45(2):832-845. PubMed ID: 27915232
[TBL] [Abstract][Full Text] [Related]
15. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state.
Lodato MA; Ng CW; Wamstad JA; Cheng AW; Thai KK; Fraenkel E; Jaenisch R; Boyer LA
PLoS Genet; 2013; 9(2):e1003288. PubMed ID: 23437007
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of DNA binding of Sox2 by the SUMO conjugation.
Tsuruzoe S; Ishihara K; Uchimura Y; Watanabe S; Sekita Y; Aoto T; Saitoh H; Yuasa Y; Niwa H; Kawasuji M; Baba H; Nakao M
Biochem Biophys Res Commun; 2006 Dec; 351(4):920-6. PubMed ID: 17097055
[TBL] [Abstract][Full Text] [Related]
17. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.
Bora-Singhal N; Nguyen J; Schaal C; Perumal D; Singh S; Coppola D; Chellappan S
Stem Cells; 2015 Jun; 33(6):1705-18. PubMed ID: 25754111
[TBL] [Abstract][Full Text] [Related]
18. Identification of two novel phenotypically distinct breast cancer cell subsets based on Sox2 transcription activity.
Wu F; Zhang J; Wang P; Ye X; Jung K; Bone KM; Pearson JD; Ingham RJ; McMullen TP; Ma Y; Lai R
Cell Signal; 2012 Nov; 24(11):1989-98. PubMed ID: 22800865
[TBL] [Abstract][Full Text] [Related]
19. Differential Nucleosome Occupancies across Oct4-Sox2 Binding Sites in Murine Embryonic Stem Cells.
Sebeson A; Xi L; Zhang Q; Sigmund A; Wang JP; Widom J; Wang X
PLoS One; 2015; 10(5):e0127214. PubMed ID: 25992972
[TBL] [Abstract][Full Text] [Related]
20. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
